Activation of two genes linked to development of atherosclerosis

Two new potential drug targets for treating arterial diseases such as atherosclerosis have been identified by researchers. By using proteomics to screen a vast number of molecules, the researchers identified PARP9 and PARP14 – two members of the PARP family of proteins – as regulators of macrophage activation, which has been linked to arterial disease by systems biology.